{"data":{"id":"us/21-cfr-862.1250","jurisdiction":"us","citation":"21 CFR 862.1250","heading":"Desoxycorticosterone test system.","body":"(a) Identification. A desoxycorticosterone test system is a device intended to measure desoxycorticosterone (DOC) in plasma and urine. DOC measurements are used in the diagnosis and treatment of patients with hypermineralocorticoidism (excess retention of sodium and loss of potassium) and other disorders of the adrenal gland.\n(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER H—MEDICAL DEVICES","PART 862—CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES","Subpart B—Clinical Chemistry Test Systems"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"badcea9ca3dc5dbc6d9627e4f2e9cd371c40e449a26433254744370c78fbd585","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-862.1245","next":"us/21-cfr-862.1255"},"notice":"GroundRules: Original legal text. Not legal advice."}